Patients with AD carrying the Trem2 R47H variant exhibited defects in microglial transcriptional activation to a certain extent [312], while R47H mice exhibited an increased expression of genes involved in oxidative stress and lipid metabolism in the brain, and decreased expression of genes involved in autophagy, growth factor signaling, and neural connectivity. This evidence concerns the gene TREM2 and Alzheimer disease.